1. Home
  2. IMNM vs GOODN Comparison

IMNM vs GOODN Comparison

Compare IMNM & GOODN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

N/A

Current Price

$20.84

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo Gladstone Commercial Corporation

GOODN

Gladstone Commercial Corporation

N/A

Current Price

$20.73

Market Cap

0.0

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
IMNM
GOODN
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Real Estate
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
N/A
IPO Year
2020
2003

Fundamental Metrics

Financial Performance
Metric
IMNM
GOODN
Price
$20.84
$20.73
Analyst Decision
Strong Buy
Analyst Count
15
0
Target Price
★ $36.00
N/A
AVG Volume (30 Days)
★ 1.0M
3.7K
Earning Date
11-05-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ 51.40
N/A
EPS
N/A
★ 0.18
Revenue
$6,941,000.00
★ $161,336,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$17,534.68
N/A
P/E Ratio
★ N/A
$115.89
Revenue Growth
N/A
★ 8.00
52 Week Low
$11.55
$20.80
52 Week High
$30.06
$23.91

Technical Indicators

Market Signals
Indicator
IMNM
GOODN
Relative Strength Index (RSI) 32.99 23.99
Support Level $19.39 N/A
Resistance Level $23.25 $22.67
Average True Range (ATR) 1.08 0.44
MACD -0.35 -0.15
Stochastic Oscillator 11.87 10.55

Price Performance

Historical Comparison
IMNM
GOODN

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About GOODN Gladstone Commercial Corporation

Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.

Share on Social Networks: